sicklecellanemianews52m
Most patients free of vaso-occlusive crises for years after Casgevy dose
Most sickle cell disease patients who received the gene-editing therapy Casgevy have been free from vaso-occlusive crises for ...
sicklecellanemianews1d
The difficult reality of dealing with invisible sickle cell complications
Invisible complications of sickle cell disease can result in a lack of understanding and proper care, says columnist.
sicklecellanemianews2d
Most SCD patients given Lyfgenia in trials stay free of VOEs: New data
The majority of SCD patients given Lyfgenia in clinical trials remained free of vaso-occlusive events (VOEs) following ...
sicklecellanemianews7d
Kanglin raises $20M to advance sickle cell gene therapy KL003
Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.
sicklecellanemianews13d
I’m learning to manage my anxiety as a sickle cell caregiver
Columnist Sylvia Amuta works to manage her anxiety after noticing that her own stress has a negative impact on her cousin ...
sicklecellanemianews9d
Trial of gene-editing therapy into SCD’s cause opens in California
Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...
sicklecellanemianews15d
Blood transfusion is a lifesaving part of my sickle cell management
Blood transfusions play a critical role in the management of sickle cell disease. They can help prevent and manage various complications as well as reduce disease severity. This lifesaving ...